Optically active anthracyclinones
US4077988A · kind A · utility
17Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 16, 1976 |
| Grant date | Mar 7, 1978 |
| Priority date | — |
| Expiry date | Jan 16, 1996 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are optically active anthracyclinones and their daunosaminyl derivatives, which are useful for the treatment of malignant diseases, particularly sarcomas, breast cancer, bronchogenic carcinoma, malignant lymphomas, neuroblastomas, acute leukemia and bladder cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.